CY1122609T1 - Υδρογονωση του ελαιου κανναβης - Google Patents

Υδρογονωση του ελαιου κανναβης

Info

Publication number
CY1122609T1
CY1122609T1 CY20191101348T CY191101348T CY1122609T1 CY 1122609 T1 CY1122609 T1 CY 1122609T1 CY 20191101348 T CY20191101348 T CY 20191101348T CY 191101348 T CY191101348 T CY 191101348T CY 1122609 T1 CY1122609 T1 CY 1122609T1
Authority
CY
Cyprus
Prior art keywords
hydrogenated
hydrogenation
acid
hemp oil
contain
Prior art date
Application number
CY20191101348T
Other languages
English (en)
Inventor
Mark Andrew Scialdone
Original Assignee
Research Grow Labs
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Research Grow Labs filed Critical Research Grow Labs
Publication of CY1122609T1 publication Critical patent/CY1122609T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78—Ring systems having three or more relevant rings
    • C07D311/80—Dibenzopyrans; Hydrogenated dibenzopyrans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30—Extraction of the material
    • A61K2236/31—Extraction of the material involving untreated material, e.g. fruit juice or sap obtained from fresh plants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Microbiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrane Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Fats And Perfumes (AREA)

Abstract

Η παρούσα εφεύρεση σχετίζεται με την εκχύλιση και την υδρογόνωση του αιθέριου ελαίου ενός φυτού κάνναβης. Η εφεύρεση περιλαμβάνει υδρογονωμένες χημικές ενώσεις και συνθέσεις, καθώς και μεθόδους παρασκευής και θεραπευτικών χρήσεων για την υποχώρηση των όγκων σε έναν ασθενή ο οποίος πάσχει από καρκίνο. Το εκχύλισμα μπορεί να περιέχει το 9-τετραϋδροκανναβινολικό οξύ και το 9-κανναβιδιολικό οξύ, και το υδρογονωμένο έλαιο κάνναβης μπορεί να περιέχει το υδρογονωμένο 9-τετραϋδροκανναβινολικό οξύ, το υδρογονωμένο 9-κανναβιδιολικό οξύ, καθώς και μίγματα και συνδυασμούς αυτών.
CY20191101348T 2015-05-07 2019-12-20 Υδρογονωση του ελαιου κανναβης CY1122609T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201562158025P 2015-05-07 2015-05-07
PCT/US2016/031441 WO2016179581A1 (en) 2015-05-07 2016-05-09 Hydrogenation of cannabis oil

Publications (1)

Publication Number Publication Date
CY1122609T1 true CY1122609T1 (el) 2021-03-12

Family

ID=57218412

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20191101348T CY1122609T1 (el) 2015-05-07 2019-12-20 Υδρογονωση του ελαιου κανναβης

Country Status (22)

Country Link
US (3) US9694040B2 (el)
EP (1) EP3291807B1 (el)
JP (1) JP2018515608A (el)
KR (1) KR20180002839A (el)
CN (1) CN107735086A (el)
AU (1) AU2016258208B2 (el)
CA (1) CA2985065A1 (el)
CY (1) CY1122609T1 (el)
DK (1) DK3291807T3 (el)
ES (1) ES2764159T3 (el)
HK (1) HK1251460A1 (el)
HR (1) HRP20192244T1 (el)
HU (1) HUE049872T2 (el)
IL (1) IL255478B (el)
LT (1) LT3291807T (el)
MX (1) MX2017014195A (el)
PT (1) PT3291807T (el)
RS (1) RS59828B1 (el)
RU (1) RU2017142561A (el)
SI (1) SI3291807T1 (el)
WO (1) WO2016179581A1 (el)
ZA (1) ZA201707529B (el)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10319475B1 (en) 2014-06-13 2019-06-11 Enigami Systems, Inc. Method and apparatus for determining relationships between medications and symptoms
US10913071B2 (en) 2016-03-09 2021-02-09 Pearson Incorporated Scalper apparatus and processing system
US10322487B1 (en) 2016-07-15 2019-06-18 Pearson Incorporated Roller mill grinding apparatus with regenerative capability
EP3548019A4 (en) * 2016-12-01 2020-08-26 Natural Extraction Systems, LLC FAST VEGETABLE OIL DISTILLER WITH A MICROWAVE AGENT
US10239808B1 (en) 2016-12-07 2019-03-26 Canopy Holdings, LLC Cannabis extracts
EP3592345A4 (en) * 2017-03-05 2020-12-30 The State of Isreal, Ministry of Agriculture & Rural Development, Agricultural Research Organization (ARO) COMPOSITIONS AND METHODS OF TREATMENT OF INFLAMMATORY DISEASES
WO2018175259A1 (en) * 2017-03-18 2018-09-27 Mcgarrah Steven M Pet food including cannabidiolic acid
US10807098B1 (en) 2017-07-26 2020-10-20 Pearson Incorporated Systems and methods for step grinding
US10272360B2 (en) 2017-08-05 2019-04-30 Priya Naturals, Inc. Phytochemical extraction system and methods to extract phytochemicals from plants including plants of the family Cannabaceae sensu stricto
WO2019056128A1 (en) * 2017-09-25 2019-03-28 Canopy Health Innovations COMPOSITIONS COMPRISING CANNABIDIOL, TETRAHYDROCANNABINOL, TERPENES AND FLAVONOIDS AND THEIR USE IN THE TREATMENT OF INSOMNIA
CA3083622A1 (en) 2017-11-27 2019-05-31 Beleave Inc. Extraction and purification of cannabinoid compounds
US10688191B2 (en) 2018-01-19 2020-06-23 Hr Biomed, Llc Delivery of a chemotherapy agent across the blood-brain barrier
US11202771B2 (en) 2018-01-31 2021-12-21 Treehouse Biotech, Inc. Hemp powder
US11325133B1 (en) 2018-07-26 2022-05-10 Pearson Incorporated Systems and methods for monitoring the roll diameter and shock loads in a milling apparatus
US20200035118A1 (en) 2018-07-27 2020-01-30 Joseph Pandolfino Methods and products to facilitate smokers switching to a tobacco heating product or e-cigarettes
US10897925B2 (en) 2018-07-27 2021-01-26 Joseph Pandolfino Articles and formulations for smoking products and vaporizers
CA3119729A1 (en) 2018-10-10 2020-04-16 Treehouse Biotech, Inc. Synthesis of cannabigerol
US10751722B1 (en) 2018-10-24 2020-08-25 Pearson Incorporated System for processing cannabis crop materials
US10785906B2 (en) 2019-02-19 2020-09-29 Pearson Incorporated Plant processing system
CA3150080A1 (en) 2019-09-06 2021-03-11 Michael Dane BACKES OPTIMIZING VOLATILE ENVIRONMENTS IN MIXTURES OF DRIED FLOWER PLANTS
US10757860B1 (en) 2019-10-31 2020-09-01 Hemp Processing Solutions, LLC Stripper apparatus crop harvesting system
US10933424B1 (en) 2019-12-11 2021-03-02 Pearson Incorporated Grinding roll improvements
WO2022115718A1 (en) * 2020-11-29 2022-06-02 Castor Trevor P Extraction, separation and purification of cannabinoids from cannabis staiva and other marijuana biomass
WO2023004414A1 (en) * 2021-07-23 2023-01-26 Colorado Chromatography, Llc A method for preparing hexahydrocannabinol
US11872259B2 (en) 2021-07-30 2024-01-16 Super Critical Ip, Llc Processes and systems for converting cannabinoids into cannabinoid derivatives and isolating the same
WO2024069589A1 (en) * 2022-09-29 2024-04-04 Blackstone Therapeutics, Llc Cannabinoid analogs and methods of use for treatment and prevention of cancer

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2419937A (en) * 1944-03-27 1947-05-06 Adams Roger Marihuana active compounds
ITMI20070522A1 (it) * 2007-03-16 2008-09-17 Eni Spa Composizione idrocarburica utile come carburante e combustibile contenente una componente petrolifera e una componente di origine biologica
GB2478595B (en) * 2010-03-12 2018-04-04 Gw Pharma Ltd Phytocannabinoids in the treatment of glioma
NL2006621C2 (en) * 2011-04-18 2012-10-22 Fytagoras B V New medical use for acidic cannabinoids.
GB2494461A (en) * 2011-09-12 2013-03-13 Gw Pharma Ltd Phytocannabinoids for use in the treatment of invasive cancers or metastases
EP2760444B1 (de) * 2011-09-29 2020-04-22 THC Pharm GmbH The Health Concept Cannabinoidcarbonsäuren, salze von cannabinoidcarbonsäuren, deren herstellung und anwendungen

Also Published As

Publication number Publication date
RU2017142561A (ru) 2019-06-10
US20170266245A1 (en) 2017-09-21
EP3291807A1 (en) 2018-03-14
HK1251460A1 (zh) 2019-02-01
US10071127B2 (en) 2018-09-11
LT3291807T (lt) 2020-01-27
ES2764159T3 (es) 2020-06-02
MX2017014195A (es) 2018-08-15
AU2016258208B2 (en) 2021-05-27
AU2016258208A1 (en) 2017-11-30
ZA201707529B (en) 2018-11-28
SI3291807T1 (sl) 2020-02-28
IL255478A (en) 2018-01-31
IL255478B (en) 2020-11-30
CN107735086A (zh) 2018-02-23
WO2016179581A1 (en) 2016-11-10
HUE049872T2 (hu) 2020-11-30
EP3291807A4 (en) 2018-05-16
US20160324909A1 (en) 2016-11-10
KR20180002839A (ko) 2018-01-08
RS59828B1 (sr) 2020-02-28
CA2985065A1 (en) 2016-11-10
JP2018515608A (ja) 2018-06-14
RU2017142561A3 (el) 2019-11-14
HRP20192244T1 (hr) 2020-03-20
US20190030102A1 (en) 2019-01-31
EP3291807B1 (en) 2019-09-25
DK3291807T3 (da) 2020-01-13
US9694040B2 (en) 2017-07-04
PT3291807T (pt) 2020-01-10

Similar Documents

Publication Publication Date Title
CY1122609T1 (el) Υδρογονωση του ελαιου κανναβης
CL2019000221A1 (es) Compuestos de tiazolo-piridina sustituida como inhibidores de malt1.
SV2018005709A (es) 3-azabiciclo[3.1.0]hexanos sustituidos como inhibidores de cetohexoquinasa
EA201890857A1 (ru) Соединения, применимые в качестве иммуномодуляторов
EA201691940A1 (ru) Новые соединения
UY37134A (es) Compuestos heteroarilos y composiciones que los contienen útiles como inhibidores de pad4
EA201691857A1 (ru) Соединения, применимые в качестве иммуномодуляторов
EA201791017A1 (ru) Гидроксисодержащие соединения, модулирующие fxr (nr1h4)
EA201791310A1 (ru) Химерные антигенные рецепторы к bcma
EA201692177A1 (ru) Соединения и композиции в качестве агонистов toll-подобного рецептора 7
EA201790273A1 (ru) Флагеллиновые композиции и их применение
CY1125150T1 (el) Ενωσεις φαινυλο-2-υδροξυ-ακετυλαμινο-2-μεθυλο-φαινυλιου
PE20160190A1 (es) Anticuerpos anti-fgfr2iiib afucosilados
EA201691568A1 (ru) Твердые фармацевтические композиции антагонистов рецепторов андрогенов
CY1120204T1 (el) Αμορφη στερεα διασπορα για χρηση σε θεραπεια καρκινου του εγκεφαλο
ECSP17038999A (es) 4-oxo-3,4-dihidro-1,2,3-benzotriazinas como moduladores de gpr139
EA201691541A1 (ru) Новые анти-baff антитела
CL2019002251A1 (es) Anticuerpos contra triptasa, composiciones de estos y usos de estos.
EA201792612A1 (ru) 6-аминохинолин-3-карбонитрилы в качестве модуляторов cot
CY1123490T1 (el) Συνθεσεις που προερχονται απο χιτοζανη
SV2019005822A (es) Metodos para tratar el cáncer de próstata
EA201790442A1 (ru) Трициклические азотсодержащие соединения для лечения инфекции, вызываемой neisseria gonorrhoeae
EA201790773A1 (ru) Композиции и способы для ингибирования биологической активности растворимых биомолекул
EA201791249A1 (ru) Получаемые из cd44v6 циклические пептиды для лечения злокачественных опухолей и связанных с ангиогенезом заболеваний
EA201501175A1 (ru) Новые соединения для лечения злокачественного новообразования